A medium-frequency local drug delivery device
By designing splicing components and handle adjustment components, the problems of instability during the splicing of the drug delivery device and inconvenient handle height were solved, enabling stable splicing and convenient transportation of multiple devices, adapting to the needs of different users, and improving the flexibility and safety of use.
Patent Information
- Application Number
- CN202522591765.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-05
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-12-05
AI Technical Summary
The existing drug delivery device is unstable during assembly, affecting the transfer effect, and the handle height is inconvenient to adjust, which affects the use effect.
The design incorporates a splicing component and a handle adjustment component. The splicing component enables quick splicing and disassembly through the cooperation of ball joint blocks and slots, ensuring stability. The handle adjustment component enables highly precise adjustment through the cooperation of threaded rods and knobs, adapting to the needs of different users.
It enables stable splicing and convenient transportation of multiple devices, reduces operation steps and labor intensity, adapts to the needs of users of different heights, and improves the flexibility and safety of use.
Smart Images

Figure CN224975638U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the technical field of medium-frequency local drug delivery devices, specifically a medium-frequency local drug delivery device. Background Technology
[0002] In the field of modern medicine, topical drug therapy has become an important treatment method for diseases such as orthopedic inflammation, soft tissue injury, and chronic pain because it can directly act on the lesion site and reduce the side effects of systemic medication. Traditional topical drug delivery methods mainly include topical application, patch application, and subcutaneous injection, but they generally suffer from technical bottlenecks such as limited drug penetration depth, insufficient targeting, and low efficacy.
[0003] Regarding the above-mentioned technical solutions, the existing transdermal delivery devices do not have a good splicing function. When a nurse pushes two transdermal delivery devices, they are unstable, which affects the transfer effect. In addition, the height of the handle is not easy to adjust, which affects the overall use effect.
[0004] Therefore, this utility model provides a medium-frequency local drug delivery device to solve the above problems. Utility Model Content
[0005] To address the shortcomings of existing technologies, this invention provides a medium-frequency local transdermal drug delivery device, which solves the problem that the existing transdermal drug delivery devices lack good splicing function and are unstable when a nurse pushes two transdermal drug delivery devices, thus affecting the transfer effect.
[0006] To achieve the above objectives, this utility model provides the following technical solution: a medium-frequency local transdermal drug delivery device, comprising a medium-frequency transdermal drug delivery therapy instrument body one and a medium-frequency transdermal drug delivery therapy instrument body two, wherein the medium-frequency transdermal drug delivery therapy instrument body two is disposed on one side of the medium-frequency transdermal drug delivery therapy instrument body one, and splicing components are fixedly installed on both sides of the medium-frequency transdermal drug delivery therapy instrument body one and the medium-frequency transdermal drug delivery therapy instrument body two, and handle adjustment components are fixedly installed on one side of the medium-frequency transdermal drug delivery therapy instrument body one and the medium-frequency transdermal drug delivery therapy instrument body two; The connecting component includes a connecting frame one, which is fixedly installed on both sides of the medium-frequency transdermal drug delivery device body one and the medium-frequency transdermal drug delivery device body two. A connecting frame is fixedly installed on one side of the connecting frame one, and slots are respectively provided at the top and bottom of the connecting frame one. A disassembly frame is fixedly installed on the other side of the connecting frame one. A spring is provided on the inner bottom wall of the disassembly frame one. Lifting plates are fixedly installed at both ends of the spring one. A ball head locking block is fixedly installed on the top of the lifting plate one. The ball head locking block is engaged with the slot.
[0007] Furthermore, the handle adjustment assembly includes a rectangular frame and a threaded rod. The rectangular frame is fixedly installed on one side of the first and second bodies of the intermediate frequency transdermal drug delivery device, respectively. The threaded rod is connected to the inner side wall of the rectangular frame via a bearing. A movable frame is threadedly connected to the side wall of the threaded rod. A connecting frame is fixedly installed on one side of the movable frame, and a handle body is fixedly installed on one side of the connecting frame.
[0008] By adopting the above technical solution, the height of the handle body can be precisely adjusted through threaded transmission to accommodate the height needs of different users.
[0009] Furthermore, the handle adjustment assembly also includes an anti-slip sleeve, which is fitted onto the side wall of the handle body.
[0010] By adopting the above technical solution, the grip friction of the handle is increased, preventing hand slippage during operation and improving safety and comfort.
[0011] Furthermore, the handle adjustment assembly also includes a knob, which is fixedly connected to the top of the threaded rod.
[0012] The above technical solution allows users to quickly rotate the threaded rod, simplifies height adjustment, and improves the ease of adjustment.
[0013] Furthermore, the handle adjustment assembly also includes stabilizing blocks, which are fixedly installed on both sides of the movable frame and are slidably connected to the rectangular frame.
[0014] By adopting the above technical solution, the sliding trajectory of the mobile frame is limited, deviation during adjustment is avoided, and the stability of height adjustment is ensured.
[0015] Furthermore, a base plate is fixedly installed at the bottom of both the first and second bodies of the intermediate frequency transdermal drug delivery device, and a protective shell is snapped onto the edge of the base plate.
[0016] By adopting the above technical solution, the edges of the base plate are protected to avoid collision damage and extend the service life of the device.
[0017] Furthermore, a plurality of casters are fixedly installed on the bottom of the base plate, and the casters are arranged relative to each other.
[0018] By adopting the above technical solution, the device can be moved flexibly in multiple directions, reducing the difficulty of transportation and improving the convenience of movement.
[0019] Beneficial effects
[0020] This invention provides a medium-frequency localized drug delivery device. Compared with the prior art, it has the following advantages:
[0021] 1. This medium-frequency local transdermal drug delivery device can be spliced together with its splicing components, making it more stable to push. Multiple devices can be pushed at a time, eliminating the need to carry each device individually during transport. This significantly reduces the operational steps and labor intensity for medical staff, avoids the risk of tipping over when pushing a single device, and saves transport space and time. It is especially suitable for scenarios where multiple devices are used in a concentrated manner, such as hospital wards and treatment rooms, improving equipment scheduling efficiency and ensuring timely equipment supply when multiple patients are treated simultaneously.
[0022] 2. This mid-frequency local transdermal drug delivery device features an adjustable handle, allowing for greater comfort when pushing the handle. This enables medical staff or users of different heights to find a suitable grip height, avoiding muscle fatigue and discomfort caused by bending over or raising their arms, and reducing the risk of strain during long-term use. It also adapts to different operating postures, such as sitting and standing, ensuring a convenient and effortless operating experience whether for short-distance movement or long-distance transport, further enhancing the device's flexibility and user compliance. Attached Figure Description
[0023] To more clearly illustrate the technical solutions in the embodiments of this utility model or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this utility model. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.
[0024] Figure 1 This is a schematic diagram of the overall structure of this utility model;
[0025] Figure 2 This is a utility model Figure 1 Enlarged view of the structure at point A in the middle;
[0026] Figure 3 This is a side view of the overall structure of this utility model;
[0027] Figure 4 This is a utility model Figure 3 Enlarged view of the structure at point B.
[0028] In the diagram: 1. Medium-frequency transdermal drug delivery device body one; 2. Medium-frequency transdermal drug delivery device body two; 3. Splicing assembly; 31. Connecting frame one; 32. Connecting frame; 33. Slot; 34. Disassembly frame; 35. Spring; 36. Lifting plate; 37. Ball head locking block; 4. Base plate; 5. Universal wheel; 6. Protective shell; 7. Handle adjustment assembly; 71. Rectangular frame; 72. Threaded rod; 73. Moving frame; 74. Connecting frame two; 75. Handle body; 76. Anti-slip sleeve; 77. Knob; 78. Stabilizing block. Detailed Implementation
[0029] It should be noted that in the description of the embodiments of this application, the terms "front," "rear," "left," "right," "up," "down," etc., indicating the orientation or positional relationship are based on the orientation or positional relationship shown in the accompanying drawings, and are only for the convenience of describing this application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this application. The terms "installation," "connection," and "linking" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a direct connection or an indirect connection through an intermediate medium; they can refer to the internal communication between two elements. For those skilled in the art, the specific meaning of the above terms in this application can be understood according to the specific circumstances.
[0030] The present application will be further described in detail below with reference to the accompanying drawings and embodiments.
[0031] Reference Figures 1 to 4 This application provides a medium-frequency local transdermal drug delivery device, including a medium-frequency transdermal drug delivery therapy instrument body 1 and a medium-frequency transdermal drug delivery therapy instrument body 2. The medium-frequency transdermal drug delivery therapy instrument body 2 is disposed on one side of the medium-frequency transdermal drug delivery therapy instrument body 1. A splicing component 3 is fixedly installed on both sides of the medium-frequency transdermal drug delivery therapy instrument body 1 and the medium-frequency transdermal drug delivery therapy instrument body 2. A handle adjustment component 7 is fixedly installed on one side of the medium-frequency transdermal drug delivery therapy instrument body 1 and the medium-frequency transdermal drug delivery therapy instrument body 2. The splicing component 3 includes a connecting frame 31, which is fixedly installed on both sides of the medium-frequency transdermal drug delivery therapy instrument body 1 and the medium-frequency transdermal drug delivery therapy instrument body 2. A connecting frame 32 is fixedly installed on one side of the connecting frame 31. The top and bottom of the connecting frame 32 are respectively provided with slots 33. A disassembly frame 34 is fixedly installed on the other side of the connecting frame 31. A spring 35 is provided on the inner bottom wall of the disassembly frame 34. Lifting plates 36 are fixedly installed on both ends of the spring 35. A ball head locking block 37 is fixedly installed on the top of the lifting plate 36. The ball head locking block 37 is engaged with the slot 33. A base plate 4 is fixedly installed on the bottom of the medium frequency transdermal drug delivery device body 1 and the medium frequency transdermal drug delivery device body 2. A protective shell 6 is engaged on the edge of the base plate 4. Multiple universal wheels 5 are fixedly installed on the bottom of the base plate 4, and the multiple universal wheels 5 are arranged opposite to each other.
[0032] In this embodiment, the disassembly frame 34 of one device is aligned with the connecting frame 32 of the other device and inserted. During insertion, the inner wall of the connecting frame 32 presses against the ball head latch 37, causing the ball head latch 37 to drive the lifting plate 36 to compress the spring 35 until the ball head latch 37 moves to the slot 33 at the top and bottom of the connecting frame 32. The spring 35 resets under the action of elastic potential energy, pushing the lifting plate 36 to drive the ball head latch 37 into the slot 33, completing the splicing and fixing of the two devices. When disassembling, the disassembly frame 34 is aligned with the connecting frame 32. Press the ball head locking block 37 inside the frame 34 to disengage the ball head locking block 37 from the slot 33, thus separating the two devices. The quick assembly and disassembly of the splicing structure is achieved through the cooperation of the spring 35 and the ball head locking block 37. At the same time, the locking cooperation between the slot 33 and the ball head locking block 37 ensures the connection stability after splicing, preventing the devices from loosening and separating during transportation. This meets the needs of centralized transportation and synchronous use of multiple devices. The model of the medium frequency transdermal drug delivery therapy instrument is HY-D01.
[0033] Reference Figures 1 to 4 In one aspect of this embodiment, the handle adjustment assembly 7 includes a rectangular frame 71 and a threaded rod 72. The rectangular frame 71 is fixedly installed on one side of the intermediate frequency transdermal drug delivery device body 1 and the intermediate frequency transdermal drug delivery device body 2, respectively. The threaded rod 72 is connected to the inner side wall of the rectangular frame 71 by a bearing. A movable frame 73 is threadedly connected to the side wall of the threaded rod 72. A connecting frame 74 is fixedly installed on one side of the movable frame 73. A handle body 75 is fixedly installed on one side of the connecting frame 74. The handle adjustment assembly 7 also includes an anti-slip sleeve 76, which is fitted onto the side wall of the handle body 75. The handle adjustment assembly 7 also includes a knob 77, which is fixedly connected to the top end of the threaded rod 72. The handle adjustment assembly 7 also includes a stabilizing block 78, which is fixedly installed on both sides of the movable frame 73. The stabilizing block 78 is slidably connected to the rectangular frame 71.
[0034] In this embodiment, the casters 5 at the bottom of the base plate 4 provide support for overall movement. The casters 5 allow the device to flexibly adjust its direction of movement, adapting to the transport needs of different scenarios such as wards and treatment rooms. The protective shell 6 at the edge of the base plate 4 effectively protects the base plate 4 and the bottom structure of the device, preventing damage to components from collisions during movement. When the handle height needs to be adjusted, the knob 77 at the top of the threaded rod 72 is turned, causing the threaded rod 72 to rotate stably on the bearing on the inner wall of the rectangular frame 71. The threaded rod 72 drives the moving frame 73 through threaded transmission. Moving vertically, the stabilizing blocks 78 on both sides of the moving frame 73 slide along the inner wall of the rectangular frame 71, limiting the offset of the moving frame 73 and ensuring the accuracy of height adjustment. The moving frame 73 drives the handle body 75 to rise and fall synchronously through the connecting frame 2 74 until it is adjusted to a position suitable for the user's height. The anti-slip sleeve 76 on the side wall of the handle body 75 increases the grip friction, prevents the hand from slipping during operation, and improves the safety and comfort of use. Ultimately, the dual optimization of the device's mobility and operational comfort is achieved. In this case, the thread helix angle is less than or equal to the equivalent friction angle.
[0035] Working principle: Align the disassembly frame 34 of one device with the connecting frame 32 of the other device and insert it. During insertion, the inner wall of the connecting frame 32 presses against the ball head latch 37, causing the ball head latch 37 to drive the lifting plate 36 to compress the spring 35 until the ball head latch 37 moves to the slot 33 at the top and bottom of the connecting frame 32. The spring 35 returns to its original position under the action of elastic potential energy, pushing the lifting plate 36 to drive the ball head latch 37 into the slot 33, completing the splicing and fixing of the two devices. When disassembling, press the ball head latch 37 towards the inside of the disassembly frame 34 to disengage the ball head latch 37 from the slot 33, thus separating the two devices. Through the cooperation of the spring 35 and the ball head latch 37, the splicing structure can be quickly disassembled and assembled. At the same time, the engagement of the slot 33 and the ball head latch 37 ensures the connection stability after splicing, preventing the devices from loosening and separating during transportation, and meeting the needs of centralized transportation and synchronous use of multiple devices.
[0036] The casters 5 at the bottom of the base plate 4 provide support for overall movement. The casters 5 allow the device to flexibly adjust its direction of movement to adapt to the transport needs of different scenarios such as wards and treatment rooms. The protective shell 6 on the edge of the base plate 4 effectively protects the base plate 4 and the bottom structure of the device, preventing damage to components caused by collisions during movement. When the handle height needs to be adjusted, turn the knob 77 at the top of the threaded rod 72 to drive the threaded rod 72 to rotate stably on the bearing on the inner wall of the rectangular frame 71. The threaded rod 72 drives the moving frame 73 to move vertically through the threaded transmission. The stabilizing blocks 78 on both sides of the moving frame 73 slide along the inner wall of the rectangular frame 71 to limit the offset of the moving frame 73 and ensure the accuracy of height adjustment. The moving frame 73 drives the handle body 75 to rise and fall synchronously through the connecting frame 2 74 until it is adjusted to a position suitable for the user's height. The anti-slip sleeve 76 on the side wall of the handle body 75 increases the grip friction to prevent the hand from slipping during operation, improving safety and comfort. Ultimately, the device achieves dual optimization of ease of movement and comfort of operation.
[0037] It should be noted that, in this document, relational terms such as "first" and "second" are used only to distinguish one entity or operation from another, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Furthermore, the terms "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such process, method, article, or apparatus.
[0038] Although embodiments of this application have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and variations can be made to these embodiments without departing from the principles and spirit of this application, the scope of which is defined by the appended claims and their equivalents.
Claims
1. An intermediate frequency local medicine penetrating device, comprising an intermediate frequency medicine penetrating treatment instrument body one (1) and an intermediate frequency medicine penetrating treatment instrument body two (2), characterized in that: The second (2) body of the intermediate frequency transdermal drug delivery device is located on one side of the first (1) body of the intermediate frequency transdermal drug delivery device. Splicing components (3) are fixedly installed on both sides of the first (1) body of the intermediate frequency transdermal drug delivery device and the second (2) body of the intermediate frequency transdermal drug delivery device. Handle adjustment components (7) are fixedly installed on one side of the first (1) body of the intermediate frequency transdermal drug delivery device and the second (2) body of the intermediate frequency transdermal drug delivery device. The splicing component (3) includes a connecting frame (31), which is fixedly installed on both sides of the medium-frequency transdermal drug delivery device body (1) and the medium-frequency transdermal drug delivery device body (2). A connecting frame (32) is fixedly installed on one side of the connecting frame (31). The top and bottom of the connecting frame (32) are respectively provided with slots (33). A disassembly frame (34) is fixedly installed on the other side of the connecting frame (31). A spring (35) is provided on the inner bottom wall of the disassembly frame (34). Lifting plates (36) are fixedly installed at both ends of the spring (35). A ball head locking block (37) is fixedly installed on the top of the lifting plate (36). The ball head locking block (37) is engaged with the slot (33).
2. The intermediate frequency local drug permeation device according to claim 1, characterized in that: The handle adjustment assembly (7) includes a rectangular frame (71) and a threaded rod (72). The rectangular frame (71) is fixedly installed on one side of the first (1) and the second (2) of the intermediate frequency transdermal drug delivery device. The threaded rod (72) is connected to the inner side wall of the rectangular frame (71) by a bearing. A movable frame (73) is threadedly connected to the side wall of the threaded rod (72). A connecting frame (74) is fixedly installed on one side of the movable frame (73). A handle body (75) is fixedly installed on one side of the connecting frame (74).
3. The medium-frequency local drug delivery device according to claim 2, characterized in that: The handle adjustment assembly (7) also includes an anti-slip sleeve (76), which is fitted onto the side wall of the handle body (75).
4. The medium-frequency local drug delivery device according to claim 3, characterized in that: The handle adjustment assembly (7) also includes a knob (77) which is fixedly connected to the top of the threaded rod (72).
5. The medium-frequency local drug delivery device according to claim 4, characterized in that: The handle adjustment assembly (7) also includes a stabilizing block (78), which is fixedly installed on both sides of the movable frame (73) and is slidably connected to the rectangular frame (71).
6. The medium-frequency local drug delivery device according to claim 1, characterized in that: The bottom of the first (1) and the second (2) of the medium-frequency transdermal drug delivery device are respectively fixedly installed with a base plate (4), and the edge of the base plate (4) is snapped with a protective shell (6).
7. A medium-frequency local drug delivery device according to claim 6, characterized in that: The bottom of the base plate (4) is fixedly equipped with multiple casters (5), and the multiple casters (5) are arranged relative to each other.
